NCT03355534

Brief Summary

Dexmedetomidine induces analgesic and sedative effects and is reported to decrease agitation during emergence after general anesthesia in various surgeries. For patients undergoing cranial aneurysm surgeries, a calm anesthesia and emergence is important. In this study, the investigatorstend to observe the effect of dexmedetomidine on maintenance and recovery of patients undergoing cranial aneurysm surgeries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 19, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 28, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

January 5, 2018

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

May 26, 2022

Status Verified

May 1, 2022

Enrollment Period

3 years

First QC Date

November 19, 2017

Last Update Submit

May 25, 2022

Conditions

Keywords

dexmedetomidinegeneral anesthesiacerebral aneurysm

Outcome Measures

Primary Outcomes (1)

  • incidence of coughing

    from end of infusing anesthetics to 2 minutes after extubation, averagely 30 minutes

Secondary Outcomes (8)

  • Ricker's agitation-sedation score

    from end of infusing anesthetics to 2 minutes after extubation, averagely 30 minutes

  • score of coughing

    from end of infusing anesthetics to 2 minutes after extubation, averagely 30 minutes

  • time to response to verbal command

    from end of infusing anesthetics to response to verbal command,averagely 20 minutes

  • time to extubation

    from end of infusing anesthetics to extubation,averagely 28 minutes

  • blood pressure before and after extubation

    from end of infusing anesthetics to 2 minutes after extubation, averagely 30 minutes

  • +3 more secondary outcomes

Study Arms (3)

nasal dexmedetomidine

EXPERIMENTAL

dexmedetomidine is given nasally, saline is given intravenously

Drug: nasal dexmedetomidineDrug: intravenous saline

intravenous dexmedetomidine

EXPERIMENTAL

saline is given nasally, dexmedetomidine is given intravenously

Drug: Intravenous dexmedetomidineDrug: nasal saline

normal saline

PLACEBO COMPARATOR

saline is given nasally and intravenously

Drug: intravenous salineDrug: nasal saline

Interventions

drug is intravenously infused to patients

intravenous dexmedetomidine

drug is nasally given to patients

nasal dexmedetomidine

saline is given to patients intravenously

nasal dexmedetomidinenormal saline

normal saline is given to patients nasally

intravenous dexmedetomidinenormal saline

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients undergoing cerebral aneurysm embolism under general anesthesia

You may not qualify if:

  • patients with bradycardia or atrioventricular heart block
  • patients with ASA(American Society of Anesthesiologists) status over 3
  • patients with body mass index(BMI)≥30kg/m2
  • patients with difficulty in communication
  • patients with ruptured aneurysm
  • patients suspected or proved to be pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xijing Hospital

Xi'an, Shaanxi, 710032, China

Location

Related Publications (5)

  • Peng K, Wu S, Liu H, Ji F. Dexmedetomidine as an anesthetic adjuvant for intracranial procedures: meta-analysis of randomized controlled trials. J Clin Neurosci. 2014 Nov;21(11):1951-8. doi: 10.1016/j.jocn.2014.02.023. Epub 2014 Jun 25.

  • Soliman RN, Hassan AR, Rashwan AM, Omar AM. Prospective, randomized controlled study to assess the role of dexmedetomidine in patients with supratentorial tumors undergoing craniotomy under general anesthesia. Middle East J Anaesthesiol. 2011 Feb;21(1):23-33.

  • Elbakry AE, Ibrahim E. Propofol-dexmedetomidine versus propofol-remifentanil conscious sedation for awake craniotomy during epilepsy surgery. Minerva Anestesiol. 2017 Dec;83(12):1248-1254. doi: 10.23736/S0375-9393.17.11873-0. Epub 2017 Jun 14.

  • Jun JH, Kim KN, Kim JY, Song SM. The effects of intranasal dexmedetomidine premedication in children: a systematic review and meta-analysis. Can J Anaesth. 2017 Sep;64(9):947-961. doi: 10.1007/s12630-017-0917-x. Epub 2017 Jun 21.

  • Sun Y, Li Y, Sun Y, Wang X, Ye H, Yuan X. Dexmedetomidine Effect on Emergence Agitation and Delirium in Children Undergoing Laparoscopic Hernia Repair: a Preliminary Study. J Int Med Res. 2017 Jun;45(3):973-983. doi: 10.1177/0300060517699467. Epub 2017 Mar 21.

MeSH Terms

Conditions

Intracranial Aneurysm

Interventions

Sodium Chloride

Condition Hierarchy (Ancestors)

Intracranial Arterial DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAneurysmVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Lize Xiong

    Air Force Military Medical University, China

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
clinical professor

Study Record Dates

First Submitted

November 19, 2017

First Posted

November 28, 2017

Study Start

January 5, 2018

Primary Completion

December 30, 2020

Study Completion

December 30, 2020

Last Updated

May 26, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations